OptimizeRx Corp (OPRX) › Weighted Average Diluted SharesOptimizeRx Corp (OPRX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2013-12-31: 21.20M2014-12-31: 24.01M2017-12-31: 9.82M2018-12-31: 11.86M2019-12-31: 13.39M2020-12-31: 14.83M2021-12-31: 17.69M2022-12-31: 17.78M2023-12-31: 17.12M2024-12-31: 18.29M2025-12-31: 19.00M19.00M2013-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3119.00M+3.9%2026-03-12From 2025-01-012024-12-3118.29M+6.8%2026-03-12From 2024-01-012023-12-3117.12M-3.7%2025-03-20From 2023-01-012022-12-3117.78M+0.5%2024-04-15From 2022-01-012021-12-3117.69M+19.3%2023-03-10From 2021-01-012020-12-3114.83M+10.8%2023-03-10From 2020-01-012019-12-3113.39M+12.9%2021-03-08From 2019-01-012018-12-3111.86M+20.8%2020-03-26From 2018-01-012017-12-319.82M—2019-03-12From 2017-01-012014-12-3124.01M+13.3%2015-09-16From 2014-01-012013-12-3121.20M—2015-09-16From 2013-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)